Lingani, Moussa http://orcid.org/0000-0002-5651-2035
Bonkian, Léa Nadège
Yerbanga, Isidore
Kazienga, Adama
Valéa, Innocent
Sorgho, Hermann
Ouédraogo, Jean Bosco
Mens, Petronella Francisca
Schallig, Henk D. F. H.
Ravinetto, Raffaella
d’Alessandro, Umberto
Tinto, Halidou
Clinical trials referenced in this document:
Documents that mention this clinical trial
In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
https://doi.org/10.1186/s12936-019-3089-z
Funding for this research was provided by:
European Community'S Seventh Framework Programme (201889)
Article History
Received: 23 July 2019
Accepted: 25 December 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: The protocol, informed consent documents, relevant supporting information, and all patient recruitment information were approved by the institutional ethics committee of Centre Muraz in Burkina Faso (Deliberation 18-2009/CE-CM). All consent forms from participants were collected.
: Consent for publication was obtained from all study participants.
: The authors declare that they have no competing interests.